| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Clinical proteomics: A need to define the field and to begin to set adequate standards.
|
Proteomics Clin Appl
|
2007
|
2.84
|
|
2
|
Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2.
|
Immunity
|
2013
|
2.74
|
|
3
|
SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset.
|
Blood
|
2011
|
2.66
|
|
4
|
Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans.
|
Circulation
|
2005
|
2.49
|
|
5
|
Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
|
Circulation
|
2007
|
2.46
|
|
6
|
Circulating miR-210 predicts survival in critically ill patients with acute kidney injury.
|
Clin J Am Soc Nephrol
|
2011
|
2.27
|
|
7
|
Erythropoietin regulates endothelial progenitor cells.
|
Blood
|
2003
|
2.18
|
|
8
|
Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans.
|
Circulation
|
2003
|
2.12
|
|
9
|
Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists.
|
Hypertension
|
2005
|
2.01
|
|
10
|
A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy.
|
Nephrol Dial Transplant
|
2012
|
1.94
|
|
11
|
Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients.
|
Crit Care
|
2008
|
1.94
|
|
12
|
CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.
|
J Am Coll Cardiol
|
2012
|
1.92
|
|
13
|
Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease.
|
Kidney Int
|
2012
|
1.92
|
|
14
|
Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis.
|
Nephrol Dial Transplant
|
2006
|
1.90
|
|
15
|
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.
|
Mol Cell Proteomics
|
2010
|
1.90
|
|
16
|
ADMA increases arterial stiffness and decreases cerebral blood flow in humans.
|
Stroke
|
2006
|
1.88
|
|
17
|
The Hannover Dialysis Outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit.
|
Nephrol Dial Transplant
|
2009
|
1.86
|
|
18
|
FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment.
|
Nephrol Dial Transplant
|
2010
|
1.78
|
|
19
|
Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study.
|
J Am Soc Nephrol
|
2005
|
1.74
|
|
20
|
CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease.
|
Eur Heart J
|
2010
|
1.73
|
|
21
|
Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease.
|
J Am Soc Nephrol
|
2002
|
1.70
|
|
22
|
Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury.
|
Crit Care
|
2010
|
1.65
|
|
23
|
Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects.
|
Circulation
|
2003
|
1.63
|
|
24
|
Recommendations for biomarker identification and qualification in clinical proteomics.
|
Sci Transl Med
|
2010
|
1.59
|
|
25
|
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics.
|
Proteomics Clin Appl
|
2008
|
1.57
|
|
26
|
Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study.
|
Am J Kidney Dis
|
2004
|
1.55
|
|
27
|
Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin.
|
J Hypertens
|
2009
|
1.54
|
|
28
|
Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome.
|
Intensive Care Med
|
2009
|
1.53
|
|
29
|
The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation.
|
Eur Heart J
|
2011
|
1.51
|
|
30
|
Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis.
|
Crit Care Med
|
2006
|
1.51
|
|
31
|
Monocyte heterogeneity in obesity and subclinical atherosclerosis.
|
Eur Heart J
|
2009
|
1.38
|
|
32
|
Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin.
|
Kidney Int
|
2003
|
1.33
|
|
33
|
Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension.
|
Arterioscler Thromb Vasc Biol
|
2005
|
1.32
|
|
34
|
Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes.
|
Kidney Int
|
2004
|
1.29
|
|
35
|
Uremia causes endothelial progenitor cell deficiency.
|
Kidney Int
|
2004
|
1.27
|
|
36
|
Statins attenuate ischemia-reperfusion injury by inducing heme oxygenase-1 in infiltrating macrophages.
|
Am J Pathol
|
2007
|
1.24
|
|
37
|
Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine.
|
Electrophoresis
|
2005
|
1.24
|
|
38
|
Proteomic analysis for the assessment of diabetic renal damage in humans.
|
Clin Sci (Lond)
|
2004
|
1.23
|
|
39
|
Osteopontin predicts survival in critically ill patients with acute kidney injury.
|
Nephrol Dial Transplant
|
2010
|
1.23
|
|
40
|
Pulmonary hypertension in CKD.
|
Am J Kidney Dis
|
2012
|
1.19
|
|
41
|
Clinical relevance of FGF-23 in chronic kidney disease.
|
Kidney Int Suppl
|
2009
|
1.18
|
|
42
|
Renal resistive index and cardiovascular and renal outcomes in essential hypertension.
|
Hypertension
|
2012
|
1.16
|
|
43
|
Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers.
|
J Chromatogr A
|
2003
|
1.16
|
|
44
|
Monocyte heterogeneity in human cardiovascular disease.
|
Immunobiology
|
2012
|
1.15
|
|
45
|
Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis.
|
J Diabetes Complications
|
2005
|
1.12
|
|
46
|
Circulating angiopoietin-2 levels increase with progress of chronic kidney disease.
|
Nephrol Dial Transplant
|
2010
|
1.08
|
|
47
|
Erythropoietin and renoprotection.
|
Curr Opin Nephrol Hypertens
|
2009
|
1.07
|
|
48
|
FGF-23: the rise of a novel cardiovascular risk marker in CKD.
|
Nephrol Dial Transplant
|
2012
|
1.07
|
|
49
|
Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
|
Nephrol Dial Transplant
|
2007
|
1.05
|
|
50
|
Pharmacokinetics of ertapenem in critically ill patients with acute renal failure undergoing extended daily dialysis.
|
Nephrol Dial Transplant
|
2008
|
1.03
|
|
51
|
Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis.
|
Clin J Am Soc Nephrol
|
2006
|
1.03
|
|
52
|
Monocyte subpopulations and cardiovascular risk in chronic kidney disease.
|
Nat Rev Nephrol
|
2012
|
1.02
|
|
53
|
Increased resistin blood levels are not associated with insulin resistance in patients with renal disease.
|
Am J Kidney Dis
|
2003
|
1.02
|
|
54
|
Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis.
|
Nat Rev Nephrol
|
2011
|
1.01
|
|
55
|
Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study.
|
J Am Soc Nephrol
|
2005
|
1.01
|
|
56
|
B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease Study.
|
Clin Chem
|
2007
|
1.00
|
|
57
|
Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure.
|
Circulation
|
2004
|
0.99
|
|
58
|
Distinct immunologic effects of different intravenous iron preparations on monocytes.
|
Nephrol Dial Transplant
|
2014
|
0.98
|
|
59
|
Endothelial progenitor cells and cardiovascular events in patients with chronic kidney disease--a prospective follow-up study.
|
PLoS One
|
2010
|
0.98
|
|
60
|
Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients.
|
Crit Care
|
2012
|
0.95
|
|
61
|
Prometheus--a new extracorporeal system for the treatment of liver failure.
|
J Hepatol
|
2003
|
0.95
|
|
62
|
Assessment of arterial stiffness for clinical and epidemiological studies: methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry.
|
Nephrol Dial Transplant
|
2013
|
0.93
|
|
63
|
Angiotensin II receptor blocker and statins lower elevated levels of osteopontin in essential hypertension--results from the EUTOPIA trial.
|
Atherosclerosis
|
2009
|
0.92
|
|
64
|
Ren sanus in corpore sano: the myth of the inexorable decline of renal function with senescence.
|
Nephrol Dial Transplant
|
2005
|
0.92
|
|
65
|
Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease.
|
Nephrol Dial Transplant
|
2010
|
0.92
|
|
66
|
Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease.
|
Eur J Clin Invest
|
2010
|
0.92
|
|
67
|
High-dose erythropoietin has no effect on short- or long-term graft function following deceased donor kidney transplantation.
|
Kidney Int
|
2011
|
0.91
|
|
68
|
Kidney graft function determines endothelial progenitor cell number in renal transplant recipients.
|
Transplantation
|
2005
|
0.91
|
|
69
|
Combined top-down and bottom-up mass spectrometric approach to characterization of biomarkers for renal disease.
|
Anal Chem
|
2005
|
0.90
|
|
70
|
SuperTAG methylation-specific digital karyotyping reveals uremia-induced epigenetic dysregulation of atherosclerosis-related genes.
|
Circ Cardiovasc Genet
|
2012
|
0.90
|
|
71
|
Bardoxolone methyl, chronic kidney disease, and type 2 diabetes.
|
N Engl J Med
|
2011
|
0.88
|
|
72
|
The relationships of markers of cholesterol homeostasis with carotid intima-media thickness.
|
PLoS One
|
2010
|
0.88
|
|
73
|
Stem cells and progenitor cells in renal disease.
|
Kidney Int
|
2005
|
0.88
|
|
74
|
The continuous erythropoietin receptor activator affects different pathways of diabetic renal injury.
|
J Am Soc Nephrol
|
2007
|
0.87
|
|
75
|
Asymmetric dimethylarginine and symmetric dimethylarginine: axis of evil or useful alliance?
|
Semin Dial
|
2009
|
0.86
|
|
76
|
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation incorporating both cystatin C and creatinine best predicts individual risk: a cohort study in 444 patients with chronic kidney disease.
|
Nephrol Dial Transplant
|
2013
|
0.86
|
|
77
|
Calcium and phosphate impact cardiovascular risk.
|
Eur Heart J
|
2012
|
0.86
|
|
78
|
Does the measurement of the difference of resistive indexes in spleen and kidney allow a selective assessment of chronic kidney injury?
|
Radiology
|
2012
|
0.86
|
|
79
|
Implementation and first results of a German chronic kidney disease registry.
|
Clin Nephrol
|
2013
|
0.85
|
|
80
|
The Prometheus device for extracorporeal support of combined liver and renal failure.
|
Blood Purif
|
2005
|
0.85
|
|
81
|
Removal selectivity of Prometheus: a new extracorporeal liver support device.
|
World J Gastroenterol
|
2006
|
0.85
|
|
82
|
Everolimus-associated interstitial pneumonitis in a patient with a heart transplant.
|
Nephrol Dial Transplant
|
2007
|
0.84
|
|
83
|
Capillary electrophoresis coupled to mass spectrometer for automated and robust polypeptide determination in body fluids for clinical use.
|
Electrophoresis
|
2004
|
0.84
|
|
84
|
Two cardiovascular risk factors in one? Homocysteine and its relation to glomerular filtration rate. A meta-analysis of 41 studies with 27,000 participants.
|
Kidney Blood Press Res
|
2008
|
0.84
|
|
85
|
Monocyte angiotensin converting enzyme expression may be associated with atherosclerosis rather than arteriosclerosis in hemodialysis patients.
|
Clin J Am Soc Nephrol
|
2010
|
0.84
|
|
86
|
Single FGF-23 measurement and time-averaged plasma phosphate levels in hemodialysis patients.
|
Clin J Am Soc Nephrol
|
2013
|
0.83
|
|
87
|
Haemodialysis-induced transient CD16+ monocytopenia and cardiovascular outcome.
|
Nephrol Dial Transplant
|
2009
|
0.83
|
|
88
|
Indices of systemic atherosclerosis are superior to ultrasound resistance indices for prediction of allograft survival.
|
Nephrol Dial Transplant
|
2009
|
0.83
|
|
89
|
FGF-23 is associated with increased disease severity and early mortality in cardiogenic shock.
|
Eur Heart J Acute Cardiovasc Care
|
2013
|
0.83
|
|
90
|
Erythropoietin prevents diabetes-induced podocyte damage.
|
Kidney Blood Press Res
|
2008
|
0.83
|
|
91
|
The role of EUTox in uremic toxin research.
|
Semin Dial
|
2009
|
0.82
|
|
92
|
T-cell numbers and antigen-specific T-cell function follow different circadian rhythms.
|
J Clin Immunol
|
2012
|
0.82
|
|
93
|
Uraemic dyslipidaemia revisited: role of high-density lipoprotein.
|
Nephrol Dial Transplant
|
2013
|
0.82
|
|
94
|
Measurement of serum soluble Klotho levels in CKD 5D patients: useful tool or dispensable biomarker?
|
Nephrol Dial Transplant
|
2012
|
0.81
|
|
95
|
Insulin resistance in CKD.
|
Clin J Am Soc Nephrol
|
2014
|
0.80
|
|
96
|
Ultrasound renal resistive index is not an organ-specific predictor of allograft outcome.
|
Nephrol Dial Transplant
|
2012
|
0.80
|
|
97
|
Cholesterol synthesis, cholesterol absorption, and mortality in hemodialysis patients.
|
Clin J Am Soc Nephrol
|
2012
|
0.80
|
|
98
|
Toll-like receptor 2 and renal allograft function.
|
Am J Nephrol
|
2008
|
0.80
|
|
99
|
Mortality and cardiovascular morbidity associated with haemoglobin levels: a pooled analysis of randomised controlled trials.
|
Nephron Clin Pract
|
2014
|
0.79
|
|
100
|
Mycobacterium fortuitum peritonitis in peritoneal dialysis and its effects on the peritoneum.
|
Clin Nephrol
|
2014
|
0.79
|
|
101
|
Erythropoietin: is it more than correcting anaemia?
|
Nephrol Dial Transplant
|
2004
|
0.79
|
|
102
|
The past, presence and future of ADMA in nephrology.
|
Nephrol Ther
|
2007
|
0.78
|
|
103
|
Best Albuminuria Measurement to Predict Cardiovascular and Renal Events.
|
Am J Nephrol
|
2016
|
0.78
|
|
104
|
Effect of experimental hyperglycaemia on renal haemodynamics in prediabetic patients with and without AT1 receptor blockade.
|
Eur J Clin Invest
|
2010
|
0.78
|
|
105
|
Changes in plasma amino acids during extracorporeal liver support by fractionated plasma separation and adsorption.
|
Artif Organs
|
2009
|
0.78
|
|
106
|
Endothelial progenitor cells in chronic kidney disease.
|
Nephrol Dial Transplant
|
2009
|
0.78
|
|
107
|
The use of echocardiography in observational clinical trials: the EURECA-m registry.
|
Nephrol Dial Transplant
|
2012
|
0.78
|
|
108
|
Successful outcome of kidney transplantation from a HBV-DNA positive donor into recipients with cleared HBV-infection using a pre-emptive therapy approach.
|
J Clin Virol
|
2010
|
0.78
|
|
109
|
Wormwood (Artemisia absinthium) for poorly responsive early-stage IgA nephropathy: a pilot uncontrolled trial.
|
Am J Kidney Dis
|
2010
|
0.78
|
|
110
|
Cholesteryl ester transfer protein activity and cardiovascular events in patients with chronic kidney disease stage V.
|
Nephrol Dial Transplant
|
2008
|
0.78
|
|
111
|
Systems biology to battle vascular disease.
|
Nephrol Dial Transplant
|
2010
|
0.78
|
|
112
|
Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus).
|
Scand J Gastroenterol
|
2006
|
0.78
|
|
113
|
The plasticity of progenitor cells--why is it of interest to the nephrologists?
|
Nephrol Dial Transplant
|
2009
|
0.77
|
|
114
|
Cellular and molecular mechanisms of tissue protection by lipophilic calcium channel blockers.
|
FASEB J
|
2006
|
0.77
|
|
115
|
Lowering asymmetric dimethylarginine--a new mechanism mediating the renoprotective effects of renin-angiotensin system inhibitors in proteinuric patients?
|
Blood Purif
|
2007
|
0.77
|
|
116
|
Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy.
|
Medicine (Baltimore)
|
2016
|
0.77
|
|
117
|
Capillary electrophoresis coupled to mass spectrometry to establish polypeptide patterns in dialysis fluids.
|
J Chromatogr A
|
2003
|
0.77
|
|
118
|
Functional changes in the ageing kidney: is there a role for asymmetric dimethylarginine?
|
Nephrol Dial Transplant
|
2003
|
0.76
|
|
119
|
HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney Disease.
|
J Am Coll Cardiol
|
2017
|
0.76
|
|
120
|
Effective achievement of hemoglobin stability with once-monthly C.E.R.A. in peritoneal dialysis patients: a prospective study.
|
Clin Drug Investig
|
2013
|
0.76
|
|
121
|
The gap between calculated and actual calcium substitution during citrate anticoagulation in an immobilised patient on renal replacement therapy reflects the extent of bone loss - a case report.
|
BMC Nephrol
|
2014
|
0.75
|
|
122
|
Do sea stars have low ADMA levels? High ADMA and low EPC count--duo infernal for the kidney.
|
Nephrol Dial Transplant
|
2010
|
0.75
|
|
123
|
Removal of asymmetric dimethylarginine during artificial liver support using fractionated plasma separation and adsorption.
|
Scand J Gastroenterol
|
2010
|
0.75
|
|
124
|
Efficacy and safety of anticoagulation with heparin versus heparin plus epoprostenol in patients undergoing extracorporeal liver support with Prometheus.
|
Artif Organs
|
2009
|
0.75
|
|
125
|
A novel adaptation of laparoscopic Tenckhoff catheter insertion technique to enhance catheter stability and function in automated peritoneal dialysis.
|
Langenbecks Arch Surg
|
2013
|
0.75
|
|
126
|
[Kidney and hypertension].
|
Herz
|
2006
|
0.75
|
|
127
|
TLR-4+ peripheral blood monocytes and cardiovascular events in patients with chronic kidney disease--a prospective follow-up study.
|
Nephrol Dial Transplant
|
2011
|
0.75
|
|
128
|
Conservative treatment of the uremic syndrome.
|
Semin Dial
|
2009
|
0.75
|
|
129
|
Kidney transplantation from a deceased donor with anuric acute kidney injury caused by rhabdomyolysis.
|
Transplantation
|
2014
|
0.75
|